Immunophenotypic Analysis of Non-Hodgkin's Lymphomas in Chinese. A Study of 75 Cases in Hong Kong

References

• Tubbs R R., Sheibani K. Immunohistology of lymphoproliferative disorders. Seminars Diagnostic Pathol 1984; 1: 272–84
   PubMedGoogle Scholar
• Knowles D M. Lymphoid cell markers, their distribution and usefulness in the immunophenotypic analysis of lymphoid neoplasms. Am J Surg Pathol 1985; 9(3 Suppl)85–108
   Google Scholar
• Gajl-Peczalska K J., Bloomfield C D., Frizzera G, . Diversity of phenotypes of non-Hodgkin's malignant lymphoma. B and T Cell Tumors UCLA Symposia on Molecular and Cellular Biology, E S. Vitetta, et al. Academic Press, New York 1982; Vol. 24: 63–7
   Google Scholar
• Lukes R J., Taylor C R., Parker J W. Immunological surface marker studies in the histopathological diagnosis of non-Hodgkin's lymphomas based on multiparameter studies of 790 cases. Malignant lymphomas: etiology, immunology, pathology, treatment, S A. Rosenberg, K S. Kaplan. Academic Press, New York 1982; 309–50
   Google Scholar
• Kadin M E., Berard C W., Nanba K, Wakasa H. Lymphoproliferative diseases in Japan and Western countries. Proceedings of the United States-Japan Seminar, September 6 and 7, 1982, in Seattle, Washington. Hum Pathol 1983; 14: 745–72
   PubMed Web of Science ®Google Scholar
• Rudders R A., DeLellis R A., AM E T., Jr, et al. Adult non-Hodgkin's lymphoma. Correlation of cell surface marker phenotype with prognosis, the new working formulation and the Rappaport and Lukes-Collins histomorphologic schemes. Cancer 1983; 52: 2289–99
   PubMed Web of Science ®Google Scholar
• Tubbs R R., Fishleder A, Weiss R A., et al. Immunohistologic cellular phenotypes of lymphoproliferative disorders. Comprehensive evaluation of 564 cases including 257 non-Hodgkin's lymphomas classified by the international working formulation. Am J Pathol 1983; 113: 207–21
   PubMed Web of Science ®Google Scholar
• Doggett R S., Wood G S., Horning S, et al. The immunologic characterization of 95 nodal and extranodal diffuse large cell lymphomas in 89 patients. Am J Pathol 1984; 115: 245–52
   PubMed Web of Science ®Google Scholar
• Lennert K. Histopathology of non-Hodgkin's lymphomas (based on the Kiel Classification). Springer-Verlag, Berlin 1981
   Google Scholar
• Christensson B, Lindemalm C, Johansson B, et al. Correlation of immunophenotype to morphology in unfavourable non-Hodgkin's lymphoma. Acta Pathol Microbiol Immunol Scand 1983; 91(A)425–33
   Google Scholar
• Lauder I, Bird C C., Child J A., Grigor I. Surface membrane phenotypic expression and treatment response of malignant lymphoma. J Pathol 1985; 145: 259–68
   PubMedGoogle Scholar
• Watanabe S, Shimosato Y, Shimoyama M, Minato K. Studies with multiple markers on malignant lymphomas and lymphoid leukemias. Cancer 1982; 50: 2372–82
   PubMedGoogle Scholar
• Pinkus G S., Said J W. Characterization of non-Hodgkin's lymphomas using multiple cell markers. Immunologic, morphologic and cytochemical studies of 72 cases. Am J Pathol 1979; 94: 349–80
   PubMedGoogle Scholar
• Xu L Z., Tu L Y., Lin Y F., et al. Phenotypic expression of non-Hodgkin's lymphomas in China. J Natl Cancer Inst 1984; 73: 635–8
   PubMedGoogle Scholar
• Rosenberg S A., Berard C W., Brown B W., et al. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas. Summary and description of a working formulation for clinical use. Cancer 1982; 49: 2112–35
   PubMed Web of Science ®Google Scholar
• Hsu S M., Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase technique: a comparison between ABC and unlabelled antibody (PAP) procedures. J Histochem Cytochem 1981; 29: 577–80
   PubMed Web of Science ®Google Scholar
• Wright D H., Issacson P G. Biopsy Pathology of the Lymphroeticular System. Chapman and Hall, London 1985; 310–21
   Google Scholar
• Li C Y., Ziesmer S C., Yam L T., et al. Practical immunocytochemical identification of human blood cells. Am J Clin Pathol 1984; 81: 204–12
   PubMedGoogle Scholar
• Stashenki P, Nadler L M., Hardy R, Schlossman S F. Characterization of a human B lymphocyte specific antigen. J Immunol 1980; 125: 1678–85
   PubMedGoogle Scholar
• Nadler L M., Anderson K C., Marti G, et al. A human B lymphocyte associated antigen on normal, mitogen activated and malignant B lymphocytes. J Immunol 1983; 131: 2440–50
   PubMedGoogle Scholar
• Howard F D., Ledbetter J A., Wong J, et al. A human T lymphocyte differentiation marker defined by monoclonal antibodies that block rosette formation. J Immunol 1981; 126: 2117–21
   PubMed Web of Science ®Google Scholar
• Van Agthoven A, Terhorst C, Reinherz E L., Schlossman S F. Characterization of T cell surface glycoproteins T1 and T3 present on all human peripheral T lymphocytes and functionally mature T lymphocytes. Eur J Immunol 1981; 11: 18–21
   PubMed Web of Science ®Google Scholar
• Reinherz E L., Kung P C., Goldstein G, Schlossman S F. Further characterization of the human inducer T cell subset defined by monoclonal antibodies. J Immunol 1979; 234: 2894–6
   Google Scholar
• Reinherz E L., Kung P C., Goldstein G, et al. Discrete stages of human intrathymic differentiation. Analysis of normal thymocytes and leukemic lymphoblasts of T lineage. Proc Natl Acad Sci USA 1980; 77: 1588–92
   PubMed Web of Science ®Google Scholar
• Reinherz E L., Kung P C., Goldstein G, Schlossman S F. A monoclonal antibody reactive with the human cytotoxic suppressor T cell subset previously defined by a heteroantiserum termed TH2. J Immunol 1980; 124: 1301–7
   PubMed Web of Science ®Google Scholar
• Todd R F., Nadler L M., Schlossman S F. Antigens on human monocytes identified by monoclonal antibodies. J Immunol 1981; 126: 1435–42
   PubMedGoogle Scholar
• Nadler L M., Stashenko P, Hardy R, et al. Monoclonal antibodies defining serologically distinct HLA-D/DR related la-like antigens in man. Hum Immunol 1981; 1: 77–90
   Google Scholar
• Ritz J, Pesando J M., Notis-McConarty J, et al. A monoclonal antibody to human acute lymphoblastic leukemia antigen. Nature 1980; 283: 583–5
   PubMed Web of Science ®Google Scholar
• Habeshaw J A., Bailey D, Stansfeld A G., Greaves M F. The cellular contents of non-Hodgin's lymphomas: a comprehensive analysis using monoclonal antibodies and other surface marker techniques. Br J Cancer 1983; 47: 327–51
   PubMedGoogle Scholar
• Knowles D M., Dodson L, Burke J S., et al. S1g− E− (“null-cell”) non-Hodgkin's lymphomas. Multiparameter determination of their B-or T-cell lineage. Am J Pathol 1985; 120: 356–70
   PubMedGoogle Scholar
• Yamanaka N, Harabuchi Y, Sambe S, et al. Non-Hodgkin's lymphoma of Waldeyer's ring and nasal cavity. Clinical and immunologic aspects. Cancer 1985; 56: 768–76
   PubMed Web of Science ®Google Scholar
• Nathwani B N., Metter G E., Gams R A., et al. Malignant lymphoma, mixed cell type, diffuse. Blood 1983; 62: 200–8
   PubMedGoogle Scholar
• Habeshaw J A. C-ALL antigen and transferrin receptor expression related to the histological class of non-Hodgkin's lymphoma, determined by the monoclonal antibodies J5 (C-ALLA) and OKT-9 (Trf). Leucocyte Typing, A Bernard, L Boumsell, J Dausset, et al. Springer-Verlag, Berlin 1984; 677–8
   Google Scholar
• Weiss L M., Crabtree G S., Rouse R V., Warnke R A. Morphologic and immunologic characterization of 50 peripheral T-cell lymphomas. Am J Pathol 1985; 118: 316–24
   PubMed Web of Science ®Google Scholar
• Knowles D M., Halper J P. Human T-cell malignancies. Correlative clinical histopathologic, immunologic and cytochemical analysis of 23 cases. Am J Pathol 1982; 106: 187–203
   PubMed Web of Science ®Google Scholar
• Stein H, Lennert K, Feller A C., Mason D Y. Immunohistological analysis of human lymphoma: Correlation of histological and immunological categories. Adv Cancer Res 1984; 42: 67–147
   PubMed Web of Science ®Google Scholar
• Stein H, Mason D Y. Immunological analysis of tissue sections in diagnosis of lymphoma. Recent Advances in Haematology, A V. Hoffbrand. Churchill Livingstone, Edinburgh 1985; 4: 127–69
   Google Scholar
• Shimoyama M, Minato K, Tobinai K, . Immunologic phenotype of tumour cells from Japanese T cell malignancies. Leucocyte Typing, A Bernard, L Boumsell, J Dausset, et al. Springer-Verlag, Berlin 1984; 534–7
   Google Scholar
• Brittinger G, Bartels H, Common H, et al. Clinical and prognostic relevance of the Kiel classification of non-Hodgkin's lymphomas. Results of a prospective multicenter study by the Kiel Lymphoma Study Group. Haematol Oncol 1984; 2: 269–306
   PubMedGoogle Scholar
• Kinoshita K, Kamihira S, Yamada Y, . Adult T cell leukaemia-lymphoma in the Nagasaki district. Gann Monograph on Cancer Research, M Hanaoka, K Takatsuki, M Shimoyama, et al. Japan Scientific Societies Press, Tokyo 1982; 128: 167–84
   Google Scholar
• Su I J., Shih L Y., Kadin M E., et al. Pathologic and immunologic characterization of malignant lymphoma in Taiwan, with special reference to retrovirus-associated adult T-cell lymphoma/leukemia. Am J Clin Pathol 1985; 84: 715–23
   PubMedGoogle Scholar
• Waterhouse J AH, Muir C S., Shanmugaratnam K, Powell J. Cancer Incidence in Five Continents. IAR, Lyon 1982; Vol. IV, IARC Scientific Publications No. 12
   Google Scholar
• Ho F CS, Todd D, Loke S L., et al. Clinico-pathological features of malignant lymphomas in 294 Hong Kong Chinese patients. Retrospective study covering an eight-year period. Int J Cancer 1984; 34: 143–8
   PubMed Web of Science ®Google Scholar